AKT1 and non-small cell lung carcinoma: LCETRL3 inhibits TDP43 degradation via the UPP and activates the NOTCH1‐PTEN‐AKT signalling, leading to AKT signalling activation in NSCLC cells and contributing to TKI resistance [50].